TTRX · Turn Therapeutics Inc.
$7.70
-0.08 (-1.03%)
At close · Jul 28
Going-concern doubt
— flagged May 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our capital resources may not be sufficient to fund operations through at least the next 12 months from the date that these unaudited condensed consolidated financial statements as of March 31, 2026 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 11, 2026
Market Cap
$229.37M
Shares
29.79M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$3.19M
-80.6%
FY2025
Diluted EPS
-$0.12
-71.4%
FY2025
Operating Cash Flow
-$2.56M
-88.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 |
|---|---|---|
| $265.57K | $245.96K | |
| $5.59M | $1.55M | |
| $53K | $47K | |
| $52.75K | $47.48K | |
| $5.86M | $1.8M | |
| -$5.86M | -$1.8M | |
| $29.58K | $28.71K | |
| $2.66M | $28.71K | |
| -$3.19M | -$1.77M | |
| USD/shares | -$0.12 | -$0.07 |
| USD/shares | -$0.12 | -$0.07 |
| shares | 27.72M | 26.64M |
| shares | 27.72M | 26.64M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.